CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net loss	$ (20,242,630)	$ (18,219,664)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	60,608	49,623
Non-cash interest expense	1,733,521	3,750,630
Non-cash lease expense	250,361	0
Change in fair value of derivative liability	3,187,380	(1,664,689)
Stock-based compensation expense	884,089	1,074,687
Conversion of convertible notes	341,136	0
Other non-cash	4,803	0
Changes in assets and liabilities:
Prepaid expenses and other current assets	(1,007,367)	(201,861)
Accounts payable and accrued expenses	(1,628,621)	3,633,394
Deferred rent	0	1,540
Other assets	(227,172)	(54,203)
Lease obligations	(249,389)	0
Net cash used in operating activities	(16,893,281)	(11,630,543)
Cash flows from investing activities
Purchase of property, plant and equipment	(29,446)	(77,414)
Payment of asset acquisition costs	(2,327,273)	0
Net cash used in investing activities	(2,356,719)	(77,414)
Cash flows from financing activities
Proceeds from sale of common stock for pre-merger financing	22,546,353	0
Proceeds from stock subscription	1,000,000	0
Purchases of treasury stock	(47,864)	0
Issuance of common stock for warrant exercises	183,034	0
Repayments of Debt	(5,290,000)	0
Proceeds from issuance of debt	6,800,000	7,300,400
Payment of debt issuance costs	(99,202)	(103,925)
Payments on financing leases	(25,866)	(11,928)
Net cash provided by financing activities	25,066,455	7,184,547
Effect of changes in exchange rate on cash	0	451
Net increase (decrease) in cash, cash equivalents and restricted cash	5,816,455	(4,522,959)
Cash, cash equivalents and restricted cash at beginning of period	1,778,613	6,301,572
Cash, cash equivalents and restricted cash at end of period	7,595,068	1,778,613
Supplemental disclosure of non-cash investing and financing transactions:
Purchase of fixed assets by entering into capital lease (Note 9)	0	63,817
Conversion of convertible notes (Note 7)	13,979,788	0
Equity issuance costs (Note 3)	1,150,000	0
Right-of-use asset related to operating leases	470,356	0
Reverse asset acquisition costs (Note 3)	$ 2,252,795	$ 0